Precipio Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 12 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly6.7M
Pathology Services Revenue Quarterly6.1M
Products Division Revenue Quarterly660K
Adjusted EBITDA Quarterly-160K
Watch Items
- CMS Reimbursement CutsTrigger: Further reductions in pathology reimbursement ratesAction: Assess impact on Pathology Services gross margins and adjust pricing or cost structures accordingly.
- Product Shipment DelaysTrigger: Customer requests to delay shipments across quartersAction: Monitor timing of revenue recognition and pipeline conversion in the Products division.
- Going Concern StatusTrigger: Working capital depletion or inability to sustain positive operating cash flowAction: Evaluate capital raising options or additional credit facilities to support long-term liquidity.
Research as of 19 Jun 2026